Rachel King, co-Founder and Chief Executive Officer of GlycoMimetics, Inc., testified today on behalf of the Biotechnology Innovation Organization (BIO) before the Joint Economic Committee. King discussed the need to build on the success of the JOBS Act, FDASIA’s “breakthrough therapies” designation, as well as policies that provide tax relief and strengthen patent protections.
When: Wednesday, October 17, 2018 8:00AM-5:00PM
Where: Inova Center for Personalized Health 3225 Gallows Rd Fairfax, Virginia 22037 United States
Women of the Virginia bioscience community from across the state will lead this full day event offering examples of working together to build a stronger bioscience industry, stronger companies and institutions, stronger teams and networks, and stronger individuals.
GlaxoSmithKline has made a $300 million equity investment in 23andMe as part of a deal that pulls it close to the consumer genetics pioneer. The partners are contributing preclinical programs to a 50-50 collaboration that will use 23andMe’s genotypic and phenotypic data to accelerate progress.
An incubator space is coming to Cherry Hill Mall — a change that points to the broader trend of shopping centers rebranding as destinations to do more than just buy clothes.
Wednesday, August 22, 2018 from 5:00 PM to 7:30 PM, Bar Louie 150 Gibbs St Rockville, MD 20850
Join BioBuzz and Emergent BioSolutions at Bar Louie in Rockville on August 22nd. Celebrating its 20th year anniversary this year, and with five locations in Maryland, Emergent is sponsoring a BioBuzz event to thank the community that it has been a part of for almost two decades.
With a dozen approvals for biosimilars under its belt already, the Food and Drug Administration has started a new effort to accelerate the development and adoption of the drugs.
Ascentage Pharma, a global biopharmaceutical company with a local hub in Maryland, has raised $150 million in Series C financing.
Is your biohealth company located in Maryland, DC or Virginia? Are you thinking of applying for a biohealth related SBIR grant? Does your technology qualify? Are you eligible? Should you apply to NIH? NSF? to other organizations?
Sign up now to learn more from one of BHI’s SBIR consultants. Office hours are scheduled next in Montgomery County August 8th and 15th. (There is no fee for this service. Depending upon your technology and stage in the business cycle, BHI may also prepay for experts to help you improve your SBIR and other non-dilutive funding applications. For more information, click here.)
Due to company graduations, co-working and individual office space is becoming available at the Montgomery County innovation centers located in Rockville and Germantown. Each location offers shared meeting and kitchenette/lunch room space, and affordable, flexible lease terms. Tenants in these facilities also have access to BHI Entrepreneurs-in-Residence analysts, and other professional staff for additional support. For more information, contact BHI.
RESI/Life Science Nation are hosting a day of partnering and networking at RESI/Life Science Nation’s inaugural First Coast Innovators Gathering. Biohealth incubators, accelerators, tech transfer offices, and research labs from the East Coast can promote their organizations and spinout companies to RESI’s audience investors and partners seeking to connect with the region’s earliest stage companies. Participating organizations also are able to offer their companies discounted attendance to day one. For more information, click here.
